About Sun Pharmaceutical Medicare Limited
Data last updated:
Sun Pharmaceutical Medicare Limited was a public limited company based in Vadodara, Gujarat, India, operated as a subsidiary of Sun Pharma Laboratories Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 January 2017.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U36900GJ2017PLC095132. Its GSTIN is 24AAYCS0886M1ZF (Gujarat).
The company had an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It was led by directors including Rakeshchandra Jagdishprasad Sinha and Prince Kalarickal Elias.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office was at Sparc Tandalja, Vadodara, Gujarat, India – 390012.
As per the financials filed for FY 2025, the company reported a revenue of ₹419.41 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net loss of ₹50.09 Cr (net margin -11.9%) and EBITDA of ₹59.25 Cr (EBITDA margin 14.1%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 39% over five years.
The company had about 915 employees on its provident fund (EPFO) records before it was dissolved.
Court records list 24 cases involving the company, including 18 filed by the company and 6 filed against it; 9 cases are pending.
The last known website on record is sunpharma.com.
Company details
Contact details
Sun Pharmaceutical Medicare Limited's registered office is in Vadodara, Gujarat. Its website is sunpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressSparc Tandalja, Vadodara, Gujarat, India – 390012
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sun Pharmaceutical Medicare Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sun Pharmaceutical Medicare is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sun Pharmaceutical Medicare Limited, buy the company report.
Financials of Sun Pharmaceutical Medicare Limited
FY 2025 filings availableSun Pharmaceutical Medicare Limited reported revenue of ₹419.41 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 23% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹59.25 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹50.09 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.1% | ||||
| Net Profit Margin | -11.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sun Pharmaceutical Medicare Limited, buy the company report.
Board of directors of Sun Pharmaceutical Medicare Limited
Sun Pharmaceutical Medicare has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakeshchandra Jagdishprasad Sinha | Director | 19 Apr 2019 | 7 Years 6 Months | As last reported |
| Prince Kalarickal Elias | Director | 29 Mar 2024 | 2 Years 7 Months | As last reported |
| Kedar Nath Senapati | Director | 29 Jan 2024 | 2 Years 9 Months | As last reported |
Peer comparison
Sun Pharmaceutical Medicare Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Niknam Chemicals Private Limited | ₹422.52 Cr (FY 2025) | 38.0% | New Delhi, Delhi, India | |||
| Lohum Materials Private Limited | ₹421.2 Cr (FY 2025) | 338.0% | Delhi, India | |||
| Recipharm Pharmaservices Private Limited | ₹421.11 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Albert David Ltd | ₹420.01 Cr (FY 2024) | 18.0% | Kolkata, West Bengal, India | |||
| Premier Explosives Limited | ₹419.57 Cr (FY 2025) | 52.0% | Secunderabad, Andhra Pradesh, India | |||
| Sun Pharmaceutical Medicare Limitedthis company | ₹419.41 Cr (FY 2025) | -₹50.09 Cr | -11.9% | 23.0% | 915 | Vadodara, Gujarat, India |
| Aspiro Pharma Limited | ₹418.29 Cr (FY 2025) | 147.0% | Markook, Telangana, India | |||
| Scott-Edil Advance Research Laboratories & Education Limited | ₹418.23 Cr (FY 2025) | 17.0% | Chandigarh, India | |||
| Senores Pharmaceuticals Limited | ₹417.51 Cr (FY 2025) | 92.0% | Ahmedabad, Gujarat, India | |||
| Mazda Colours Limited | ₹416.39 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Assam Petro Chemicals Ltd | ₹416.2 Cr (FY 2025) | 365.0% | Gmc, Assam, India |
To see the full peer comparison of Sun Pharmaceutical Medicare Limited, buy the company report.
Auditor
Sun Pharmaceutical Medicare Limited is audited by S R B C & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2023 | 324982E/E300003 |
Shareholding
The shareholding of Sun Pharmaceutical Medicare Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sun Pharmaceutical Medicare Limited, buy the company report.
Legal cases
Sun Pharmaceutical Medicare Limited has 24 court cases on record: 18 filed by Sun Pharmaceutical Medicare, 6 filed against it. 9 cases are pending and 15 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 23 | 5 | 9 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed by the company against Biocorp Life Sciences Private Limited and 1 other | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Alenvision Pharma Pvt. Ltd & Anr. | Pending |
| High Court of Delhi | Court case (EX.P.) | Filed by the company against Tripada Healthcare Pvt. Ltd. & Anr. | Pending |
| Bombay High Court | Court case (COMIP) | Filed by the company against Fitwel Pharmaceuticals Private Limited and 3 others | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed by the company against Biocorp Life Sciences Private Limited and Anr | Pending |
To see the full case history of Sun Pharmaceutical Medicare Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Sun Pharmaceutical Medicare Limited has 59 MSME Form 1 returns on record between 2017 and 2024, listing 2,133 overdue payments to 212 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 212)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Pharmasecure Product Authentication Services India Private Limited | |||
| Atfah Packaging Private Limited | |||
| Hi-Tech Printing Services Private Limited | |||
| Vijay Transtech Private Limited |
To see the full MSME payment records of Sun Pharmaceutical Medicare Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Sun Pharmaceutical Medicare Limited has a workforce of 915 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
Sun Pharmaceutical Medicare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAYCS0886M1ZF | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sun Pharmaceutical Medicare Limited, buy the company report.
Recent activity
Sun Pharmaceutical Medicare Limited has 10 board changes on record since 2019: 3 appointments and 7 cessations. The latest: Kedar Nath Senapati ceased to be Additional Director on 26 Sep 2024.
1 earlier event is in the company report.
News
Frequently asked questions
Sun Pharmaceutical Medicare has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Sun Pharmaceutical Medicare was a public limited company based in Vadodara, Gujarat, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 January 2017 and is registered under CIN U36900GJ2017PLC095132. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Sun Pharmaceutical Medicare was incorporated on 16 January 2017. It is registered with the Registrar of Companies, Ahmedabad.
Sun Pharmaceutical Medicare had 3 directors:
- Rakeshchandra Jagdishprasad Sinha - Director
- Prince Kalarickal Elias - Director
- Kedar Nath Senapati - Director
The CIN (Corporate Identification Number) of Sun Pharmaceutical Medicare is U36900GJ2017PLC095132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sun Pharmaceutical Medicare is at Sparc Tandalja, Vadodara, Gujarat, India – 390012.
Sun Pharmaceutical Medicare can be reached through the website sunpharma.com. Its registered office is in Vadodara, Gujarat, India.
The latest financial statements of Sun Pharmaceutical Medicare on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Sun Pharmaceutical Medicare is 24AAYCS0886M1ZF, registered in Gujarat.
Sun Pharmaceutical Medicare operated in the pharma industry, in the drug formulation and development segment.
The peers of Sun Pharmaceutical Medicare by revenue are Niknam Chemicals Private Limited, Lohum Materials Private Limited, Recipharm Pharmaservices Private Limited, Albert David Ltd, Premier Explosives Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sun Pharmaceutical Medicare has 59 MSME Form 1 returns on record between 2017 and 2024, listing 2,133 overdue payments to 212 micro and small suppliers. The latest return was filed on 01 May 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
